Brain and Coordination Changes Induced By Robotics and FES Treatment Following Stroke

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00237744
Collaborator
(none)
40
1
3
77
0.5

Study Details

Study Description

Brief Summary

The long-range goal of this work is to identify how to target treatment so that the brain is functionally re-organized to produce movement. This study will compare treatment response to robotics versus functional neuromuscular stimulation.

Condition or Disease Intervention/Treatment Phase
  • Device: Robotics training for shoulder elbow.
  • Device: Surface Functional Neuromuscular Stimulation
  • Other: whole arm motor learning
N/A

Detailed Description

Methods. Up to ninety-six chronic stroke subjects (> 12 months post stroke) will be randomized to one of the treatment groups: Wrist/hand Functional Electrical Stimulation (FES)+whole arm motor learning group; shoulder/elbow robotics + whole arm motor learning group; and whole arm motor learning group. For all groups, treatment will offered 5 hrs/day, 5 days/week, for 12 weeks. All three treatment groups will receive motor learning therapy. For the Wrist/hand FES+whole arm motor learning group, there will be the addition of FES during treatment. For the Shoulder/elbow robotics + whole arm motor learning group there will be the addition of robotics training. Outcome measures will be collected at weeks 1, 6, 12, and three months after the end of treatment. Measures will include muscle strength (Manual Muscle Testing); coordination of joint movement (Fugl-Meyer Coordination Scale); motor control of target acquisition, pathway maintenance; and smoothness of movement (robotics measures); performance of 13 functional tasks (Arm Motor Ability Test); and quality of life (Stroke Impact Scale). Measures of brain function will be non-invasive and will include cognitive planning time, cognitive effort level, and location of brain activity during simple shoulder and arm movements. Changes in brain function measures will reflect plasticity or adaptability in response to treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
CNS Plasticity Induced By Motor Learning Technologies Following Stroke
Study Start Date :
Apr 1, 2005
Actual Primary Completion Date :
Sep 1, 2011
Actual Study Completion Date :
Sep 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Wrist/Hand FES + Whole Arm Motor Learning

Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, who received whole arm motor learning training and FES of the wrist/hand.

Device: Surface Functional Neuromuscular Stimulation
training utilizing FNS to assist with movement practice

Other: whole arm motor learning
intervention utilizing motor learning training principles to perform part and whole task practice of meaningful everyday functional tasks.

Experimental: Shoulder/Elbow Robotics + Whole Arm Motor Learning

Subjects>6 months following first stroke with diminished upper limb strength, coordination and function, who received whole arm motor learning and shoulder/elbow robotics.

Device: Robotics training for shoulder elbow.
training utilizing a robot to assist with movement practice

Other: whole arm motor learning
intervention utilizing motor learning training principles to perform part and whole task practice of meaningful everyday functional tasks.

Experimental: Whole Arm Motor Learning

Subjects>6 months following first stroke with diminished upper limb strength, coordination and function who received whole arm motor learning training without addition of FES or Robotics

Other: whole arm motor learning
intervention utilizing motor learning training principles to perform part and whole task practice of meaningful everyday functional tasks.

Outcome Measures

Primary Outcome Measures

  1. AMAT [prior to treatment and following 3 months of treatment]

    The AMAT is a measure of complex functional task performance of a variety of specified tasks and is measured in seconds summed across the various tasks. A higher score is indicative of decreased performance on the measure. A max score of 3000 seconds would indicate inability to perform any portion of the test.

  2. M1 Activation Absolute Change Score [at baseline and following 3 months of treatment]

    A measure of brain activation change in the area of M1 following intervention (pre to post intervention). A number greater than 0 indicates a change in brain activation in the area of M1. The maximum voxel activation for a healthy adult in the studied region of Interest (M1) is 659.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Medically stable and at least 12 months post stroke.

  • Difficulty using upper limb for functional tasks.

  • Age >21 years

Exclusion Criteria:

uncontrolled, chronic medical condition

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Medical Center, Cleveland Cleveland Ohio United States 44106

Sponsors and Collaborators

  • US Department of Veterans Affairs

Investigators

  • Principal Investigator: Janis Daly, PhD MS, VA Medical Center, Cleveland

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
US Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00237744
Other Study ID Numbers:
  • B3709-I
First Posted:
Oct 12, 2005
Last Update Posted:
Oct 13, 2014
Last Verified:
Oct 1, 2014
Keywords provided by US Department of Veterans Affairs
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details Subjects were recruited by word of mouth and from an advertisement flyer.
Pre-assignment Detail
Arm/Group Title Wrist/Hand FES + Whole Arm Motor Learning Shoulder/Elbow Robotics + Whole Arm Motor Learning Whole Arm Motor Learning
Arm/Group Description Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, who received whole arm motor learning and wrist/hand FES. Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, who received whole arm motor learning and shoulder/elbow robotics. Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, who received whole arm motor learning.
Period Title: Overall Study
STARTED 11 11 18
COMPLETED 8 10 18
NOT COMPLETED 3 1 0

Baseline Characteristics

Arm/Group Title Shoulder/Elbow Robotics + Whole Arm Motor Learning Wrist/Hand FES + Whole Arm Motor Learning Whole Arm Motor Learning Total
Arm/Group Description Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, and impairment of shoulder/elbow > wrist hand. Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, and impairment of wrist hand >shoulder/elbow Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, and impairment of shoulder/elbow=wrist hand Total of all reporting groups
Overall Participants 11 11 18 40
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
0
0%
Between 18 and 65 years
9
81.8%
9
81.8%
13
72.2%
31
77.5%
>=65 years
2
18.2%
2
18.2%
5
27.8%
9
22.5%
Sex: Female, Male (Count of Participants)
Female
3
27.3%
5
45.5%
4
22.2%
12
30%
Male
8
72.7%
6
54.5%
14
77.8%
28
70%
Region of Enrollment (participants) [Number]
United States
11
100%
11
100%
18
100%
40
100%

Outcome Measures

1. Primary Outcome
Title AMAT
Description The AMAT is a measure of complex functional task performance of a variety of specified tasks and is measured in seconds summed across the various tasks. A higher score is indicative of decreased performance on the measure. A max score of 3000 seconds would indicate inability to perform any portion of the test.
Time Frame prior to treatment and following 3 months of treatment

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Shoulder/Elbow Robotics+Whole Arm Motor Learning Wrist/Hand FES+Whole Arm Motor Learning Whole Arm Motor Learning Group
Arm/Group Description Subjects>6 months following first stroke with diminished upper limb strength, coordination and function, who received whole arm motor learning and shoulder/elbow robotics. The intervention provided in this group included surface FES and whole are motor learning. Interventions included whole arm motor learning, FES and Robotics.
Measure Participants 10 8 18
Pre Treatment AMAT
1693
(631)
1693
(947)
1556
(703)
Post Treatment AMAT
1386
(572)
1341
(900)
1187
(703)
2. Primary Outcome
Title M1 Activation Absolute Change Score
Description A measure of brain activation change in the area of M1 following intervention (pre to post intervention). A number greater than 0 indicates a change in brain activation in the area of M1. The maximum voxel activation for a healthy adult in the studied region of Interest (M1) is 659.
Time Frame at baseline and following 3 months of treatment

Outcome Measure Data

Analysis Population Description
This is a sub sample of subjects eligible to undergo fMRI testing. A total of 23 subjects were eligible (5 subjects in the wrist/hand FES+ whole arm motor learning group; 8 subjects in the shoulder/elbow robotics+whole arm motor learning group and 10 subjects in the Whole arm motor learning group).
Arm/Group Title Wrist/Hand FES + Whole Arm Motor Learning Shoulder/Elbow Robotics + Whole Arm Motor Learning Whole Arm Motor Learning
Arm/Group Description Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, who received whole arm motor learning and wrist/hand FES. Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, who received whole arm motor learning and shoulder/elbow robotics. Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, who received whole arm motor learning.
Measure Participants 5 8 10
Mean (Standard Deviation) [voxels]
359.6
(323.3)
489.88
(505.8)
429.7
(327.2)

Adverse Events

Time Frame Adverse event data were collected for the duration of study participation.
Adverse Event Reporting Description
Arm/Group Title Wrist/Hand FES + Whole Arm Motor Learning Shoulder/Elbow Robotics + Whole Arm Motor Learning Whole Arm Motor Learning
Arm/Group Description Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, and impairment of wrist/hand> shoulder/elbow.) Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, and impairment of shoulder/elbow > wrist hand. Subjects > 6 months following first stroke with diminished upper limb strength, coordination and function, and impairment of shoulder/elbow = wrist hand.
All Cause Mortality
Wrist/Hand FES + Whole Arm Motor Learning Shoulder/Elbow Robotics + Whole Arm Motor Learning Whole Arm Motor Learning
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN) / (NaN)
Serious Adverse Events
Wrist/Hand FES + Whole Arm Motor Learning Shoulder/Elbow Robotics + Whole Arm Motor Learning Whole Arm Motor Learning
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/11 (0%) 0/11 (0%) 0/18 (0%)
Other (Not Including Serious) Adverse Events
Wrist/Hand FES + Whole Arm Motor Learning Shoulder/Elbow Robotics + Whole Arm Motor Learning Whole Arm Motor Learning
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/11 (0%) 0/11 (0%) 0/18 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center
Organization Malcom Randall VA Medical Center, Gainesville Florida
Phone (352) 376-1611 ext 6603
Email jjd17@case.edu
Responsible Party:
US Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00237744
Other Study ID Numbers:
  • B3709-I
First Posted:
Oct 12, 2005
Last Update Posted:
Oct 13, 2014
Last Verified:
Oct 1, 2014